MedWatch: an important instrument for postlicensing surveillance.
Aledort
L M
LM
D016907:Adverse Drug Reaction Reporting Systems; D001779:Blood Coagulation Factors / Q000009:adverse effects; D005167:Factor VII / Q000009:adverse effects; D015942:Factor VIIa; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy; D006801:Humans; D011358:Product Surveillance, Postmarketing; D011994:Recombinant Proteins / Q000009:adverse effects; D013927:Thrombosis / Q000139:chemically induced
D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; C065655:anti-inhibitor coagulant complex; D015942:Factor VIIa